BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : BEAM, BOL, KERA, LASE, LCAV, LVCI, LZRC, VISX, SNRS, STAA

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: virgil vancleave who wrote (66)	4/23/1999 12:03:00 PM
From: neelu	Read Replies (1) of 253

I believe that because they are lowering the price of their lasers far below VISX, their sales will increase. ALso because of their relative low valuation (as compared with their sector) they should have a good run up, but do watch it after the run up, because the demand will dry up from the competition and perceived quality of ablation when compared to VISX, Nidex, and marketing

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next